These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19121330)

  • 21. A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation.
    Mechan AO; O'Shea E; Elliott JM; Colado MI; Green AR
    Psychopharmacology (Berl); 2001 Jun; 155(4):413-8. PubMed ID: 11441431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge.
    Connor TJ; Kelly JP; McGee M; Leonard BE
    Life Sci; 2000 Aug; 67(13):1601-12. PubMed ID: 10983854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy).
    Sprague JE; Banks ML; Cook VJ; Mills EM
    J Pharmacol Exp Ther; 2003 Apr; 305(1):159-66. PubMed ID: 12649364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memantine attenuates 3,4-methylenedioxymethamphetamine-induced hyperthermia in rats.
    Nisijima K; Kuboshima K; Shioda K; Yoshino T; Iwamura T; Kato S
    Neurosci Lett; 2012 Dec; 531(2):198-203. PubMed ID: 23142720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity.
    Goni-Allo B; O Mathúna B; Segura M; Puerta E; Lasheras B; de la Torre R; Aguirre N
    Psychopharmacology (Berl); 2008 Apr; 197(2):263-78. PubMed ID: 18074122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
    Puerta E; Hervias I; Goñi-Allo B; Lasheras B; Jordan J; Aguirre N
    J Neurochem; 2009 Feb; 108(3):755-66. PubMed ID: 19187094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia.
    Capela JP; Meisel A; Abreu AR; Branco PS; Ferreira LM; Lobo AM; Remião F; Bastos ML; Carvalho F
    J Pharmacol Exp Ther; 2006 Jan; 316(1):53-61. PubMed ID: 16183702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of 3,4-methylenedioxymethamphetamine and 4-methylthioamphetamine on rat liver mitochondrial function.
    Custódio JB; Santos MS; Gonçalves DI; Moreno AJ; Fernandes E; Bastos ML; Carvalho F; Vicente JA; Fernandes MA
    Toxicology; 2010 Apr; 270(2-3):99-105. PubMed ID: 20138954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylenedioxymethamphetamine (ecstasy)-related hyperthermia.
    Patel MM; Belson MG; Longwater AB; Olson KR; Miller MA
    J Emerg Med; 2005 Nov; 29(4):451-4. PubMed ID: 16243206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
    Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature.
    Carvalho M; Carvalho F; Remião F; de Lourdes Pereira M; Pires-das-Neves R; de Lourdes Bastos M
    Arch Toxicol; 2002 Apr; 76(3):166-72. PubMed ID: 11967622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of temperature changes and neurovascular coupling in rat brain following 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") exposure.
    Coman D; Sanganahalli BG; Jiang L; Hyder F; Behar KL
    NMR Biomed; 2015 Oct; 28(10):1257-66. PubMed ID: 26286889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic exposure to ethanol exacerbates MDMA-induced hyperthermia and exposes liver to severe MDMA-induced toxicity in CD1 mice.
    Pontes H; Duarte JA; de Pinho PG; Soares ME; Fernandes E; Dinis-Oliveira RJ; Sousa C; Silva R; Carmo H; Casal S; Remião F; Carvalho F; Bastos ML
    Toxicology; 2008 Oct; 252(1-3):64-71. PubMed ID: 18761051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.
    Colado MI; Camarero J; Mechan AO; Sanchez V; Esteban B; Elliott JM; Green AR
    Br J Pharmacol; 2001 Dec; 134(8):1711-23. PubMed ID: 11739248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus.
    Pérez-Hernández M; Fernández-Valle ME; Rubio-Araiz A; Vidal R; Gutiérrez-López MD; O'Shea E; Colado MI
    Neuropharmacology; 2017 May; 118():157-166. PubMed ID: 28322979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotoxicity mechanisms of thioether ecstasy metabolites.
    Capela JP; Macedo C; Branco PS; Ferreira LM; Lobo AM; Fernandes E; Remião F; Bastos ML; Dirnagl U; Meisel A; Carvalho F
    Neuroscience; 2007 Jun; 146(4):1743-57. PubMed ID: 17467183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute administration of 3,4-methylenedioxymethamphetamine (MDMA) induces oxidative stress, lipoperoxidation and TNFα-mediated apoptosis in rat liver.
    Cerretani D; Bello S; Cantatore S; Fiaschi AI; Montefrancesco G; Neri M; Pomara C; Riezzo I; Fiore C; Bonsignore A; Turillazzi E; Fineschi V
    Pharmacol Res; 2011 Nov; 64(5):517-27. PubMed ID: 21864684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine ("ecstasy").
    Fiege M; Wappler F; Weisshorn R; Gerbershagen MU; Menge M; Schulte Am Esch J
    Anesthesiology; 2003 Nov; 99(5):1132-6. PubMed ID: 14576550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats.
    Walker QD; Williams CN; Jotwani RP; Waller ST; Francis R; Kuhn CM
    Psychopharmacology (Berl); 2007 Jan; 189(4):435-45. PubMed ID: 17019566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology: uncoupling the agony from ecstasy.
    Mills EM; Banks ML; Sprague JE; Finkel T
    Nature; 2003 Nov; 426(6965):403-4. PubMed ID: 14647371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.